Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors

Journal of Clinical Investigation

Volumn 110, Issue 11, 2002, Pages 1599-1601

  Al Awqati, Qais ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORIDE CHANNEL BLOCKING AGENT; ELECTROLYTE; PROTEIN INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANTIBIOTIC THERAPY; CHOLERA; CYSTIC FIBROSIS; DIARRHEA; ELECTROLYTE TRANSPORT; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 0036896361     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0217301     Document Type: Note

References (17)

1. Carpenter, C.C., Sack, R.B., Feeley, J.C., and Steenberg, R.W. 1968. Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J. Clin. Invest. 47:1210-1220.
2. Kimberg, D.V., Field, M., Johnson, J., Henderson, A., and Gershon, E. 1971. Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J. Clin. Invest. 50:1218-1230.
3. Moss, J., and Vaughan, M. 1977. Choleragen activation of solubilized adenylate cyclase: Requirement for GTP and protein activator for demonstration of enzymatic activity. Proc. Natl. Acad. Sci. USA. 74:4396-4400.
4. Field, M., Fromm, D., Al-Awqati, Q., and Greenough, W.B., III. 1972. Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J. Clin. Invest. 51:796-804.
5. Field, M., Graf, L.H., Jr., Laird, W.J., and Smith, P.L. 1978. Heat-stable enterotoxin of Escherichia coli: In vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc. Natl. Acad. Sci. USA. 75:2800-2804.
6. Victora, C.G., Bryce, J., Fontaine, O., and Monasch, R. 2000. Reducing deaths from diarrhoea through oral rehydration therapy. Bulletin of the World Health Organization. 78:1246-1255.
7. Ma, T., et al. 2002. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J. Clin. Invest. 110:1651-1658. doi:10.1172/JCI200216112.
8. +-ATPase. J. Clin. Invest. 110:1739-1747. doi:10.1172/JCI200215695.
9. Frizzell, R.A., Field, M., and Schultz, S.G. 1979. Sodium-coupled chloride transport by epithelial tissues. Am. J. Physiol. 236:F1-F8.
10. Anderson, M.P., Sheppard, D.N., Berger, H.A., and Welsh, M.J. 1992. Chloride channels in the apical membrane of normal and cystic fibrosis airway and intestinal epithelia. Am. J. Physiol. 263:L1-L14.
11. Riordan, J.R., et al. 1989. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science. 245:1066-1073.
12. Schwiebert, E.M., Benos, D.J., Egan, M.E., Stutts, M.J., and Guggino, W.B. 1999. CFTR is a conductance regulator as well as a chloride channel. Physiol. Rev. 79:S145-S166.
13. Ma, T., et al. 2002. High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening. J. Biol. Chem. 277:37235-37241.
14. Al-Awqati, Q., Field, M., and Greenough, W.B., III. 1974. Reversal of cyclic AMP-mediated intestinal secretion by ethacrynic acid. J. Clin. Invest. 53:687-692.
15. da Cunha Ferreira, R.M., and Cash, R.A. 1990. History of the development of oral rehydration therapy. Clin. Ther. 12(Suppl. A):2-11.
16. Davidow, C.J., Maser, R.L., Rome, L.A., Calvet, J.P., and Grantham, J.J. 1996. The cystic fibrosis transmembrane conductance regulator mediates transepithetial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. Kidney. Int. 50:208-218.
17. Milewski, J.M., and Frizzell, R.A. 1999. Role of CFTR in airway disease. Physiol Rev. 79:S215-S255.